Los Angeles Capital Management LLC Buys Shares of 12,763 LifeMD, Inc. (NASDAQ:LFMD)

Los Angeles Capital Management LLC purchased a new position in shares of LifeMD, Inc. (NASDAQ:LFMD) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 12,763 shares of the company’s stock, valued at approximately $88,000.

A number of other institutional investors have also made changes to their positions in LFMD. EntryPoint Capital LLC acquired a new stake in LifeMD in the 1st quarter valued at $89,000. Russell Investments Group Ltd. acquired a new stake in shares of LifeMD in the 4th quarter valued at approximately $153,000. Virtu Financial LLC bought a new position in shares of LifeMD in the first quarter valued at $249,000. Thompson Davis & CO. Inc. increased its holdings in LifeMD by 182.8% during the first quarter. Thompson Davis & CO. Inc. now owns 40,000 shares of the company’s stock worth $411,000 after buying an additional 25,855 shares during the last quarter. Finally, Hussman Strategic Advisors Inc. bought a new stake in LifeMD during the first quarter worth $432,000. Institutional investors own 35.52% of the company’s stock.

Analyst Upgrades and Downgrades

LFMD has been the subject of a number of analyst reports. KeyCorp decreased their price objective on shares of LifeMD from $12.00 to $10.00 and set an “overweight” rating for the company in a research report on Thursday, July 11th. Cantor Fitzgerald reissued an “overweight” rating and set a $15.00 price target on shares of LifeMD in a research report on Tuesday, August 20th. Finally, B. Riley began coverage on LifeMD in a research note on Friday, August 23rd. They set a “buy” rating and a $11.00 target price for the company. Six analysts have rated the stock with a buy rating, According to data from MarketBeat.com, LifeMD has a consensus rating of “Buy” and a consensus target price of $12.00.

LifeMD Price Performance

LFMD stock opened at $5.13 on Tuesday. The company’s 50-day moving average price is $5.77 and its two-hundred day moving average price is $7.89. LifeMD, Inc. has a 12 month low of $4.05 and a 12 month high of $12.88. The company has a quick ratio of 0.83, a current ratio of 0.87 and a debt-to-equity ratio of 10.83. The firm has a market cap of $214.21 million, a P/E ratio of -6.93 and a beta of 1.19.

LifeMD (NASDAQ:LFMD) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.06). The business had revenue of $50.66 million for the quarter, compared to analyst estimates of $48.47 million. During the same period in the prior year, the company posted ($0.23) EPS. On average, analysts anticipate that LifeMD, Inc. will post -0.49 earnings per share for the current fiscal year.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.